Elixicure CBD-Infused Pain Relief Product Receives FDA Certification

SANTA ANA, Calif., Jan. 29, 2020 /PRNewswire/ — Elixicure’s Over-The-Counter Drug Registration has been Certified by the U.S. Food and Drug Administration (FDA) for its Elixicure CBD-Infused Pain Relief products following a successful year-long process, announced Elixicure Chief of Business Development Yaniv Kotler. This marks the very first, and currently only, Over-The-Counter (OTC) Topical drug with Cannabidiol (CBD) to be registered and certified to date.

READ MORE

Elixicure CBD-Infused Pain Relief Product Receives FDA Certification

I recently came across a mention on Instagram that Elixicure was the “first and only FDA approved over-the-counter CBD product,” and I was stopped dead in my tracks wondering how I could have missed such a monumental moment in cannabis history. I immediately began researching. First, the FDA website. No announcements of a new CBD approval or about Elixicure or its labeler, Honest Globe. Then my most trusted cannabis news sources. Nothing. I moved to a google search and found: an online retail site…

READ MORE

Elixicure adds Don Donovan to the Corporate Advisory Board and as Chief Marketing Officer

Don is an inventor, data scientist, and author of “The Right to Succeed™, A marketing Approach Guaranteed to Deliver.” Don worked at Proctor & Gamble as general management, client relations, and head of Consumer Packaged Goods for over 20 years. In 2005 he founded and became the CEO of Baker Street Solutions – a marketing consulting firm. He is Baker Street’s “Discovery” guru! Don’s vision for how consumer behavior is translated into predictive modeling is the basis for his extraordinary career.

READ MORE